These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 33690086)

  • 1. Challenges in multiple sclerosis care: Results from an international mixed-methods study.
    Péloquin S; Schmierer K; Leist TP; Oh J; Murray S; Lazure P
    Mult Scler Relat Disord; 2021 May; 50():102854. PubMed ID: 33690086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical decision-making in multiple sclerosis: Challenges reported internationally with emerging treatment complexity.
    Ng P; Murray S; Hayes SM
    Mult Scler Relat Disord; 2015 Jul; 4(4):320-8. PubMed ID: 26195050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing Shared Decision-Making for Multiple Sclerosis: The MS-SUPPORT Tool.
    Col NF; Solomon AJ; Alvarez E; Pbert L; Ionete C; BerriosMorales I; Chester J; Kutz C; Iwuchukwu C; Livingston T; Springmann V; Col HV; Ngo LH
    Mult Scler Relat Disord; 2023 Dec; 80():105092. PubMed ID: 37931489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of the patient's perspective in decision-making in multiple sclerosis: Results of the OwnMS patient perspectives study.
    Florio-Smith J; Ayer M; Colhoun S; Daykin N; Hamill B; Liu X; Rogers E; Thomson A; Balzan RP
    Mult Scler Relat Disord; 2023 Jul; 75():104757. PubMed ID: 37210990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results from SPECTRUM: A survey of healthcare professionals to understand current diagnosis and management practices for secondary progressive multiple sclerosis in the United Kingdom.
    Duddy M; Wilkinson C; Medhurst S; Rhys K
    Mult Scler Relat Disord; 2021 Oct; 55():103174. PubMed ID: 34399317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying the educational needs of physicians in pediatric epilepsy in order to improve care: results from a needs assessment in Germany, Spain, and the United States.
    Murray S; Labbé S; Kothare S; Málaga I; Kluger G; Ogden P; Lazure P; Arzimanoglou A
    Epileptic Disord; 2018 Aug; 20(4):239-256. PubMed ID: 30078771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced practice nursing implementation in France: A mixed-method study.
    Toniolo J; Berger V; Deplanque A; Langlois M; Pelletier I; Ngoungou EB; Preux PM; Beloni P
    J Adv Nurs; 2024 Dec; 80(12):5076-5089. PubMed ID: 38953563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial.
    Smyth P; Watson KE; Tsuyuki RT
    Trials; 2021 Nov; 22(1):785. PubMed ID: 34749784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies.
    Burtchell J; Clemmons D; Clemmons J; Sabutis T; Rosenberg A; Graves J; Sweeney ML; Kramer J; Ziehn M; Brown B; Weiss JL; Obeidat AZ
    Neurol Ther; 2022 Sep; 11(3):955-979. PubMed ID: 35608740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment selection and experience in multiple sclerosis: survey of neurologists.
    Hanson KA; Agashivala N; Wyrwich KW; Raimundo K; Kim E; Brandes DW
    Patient Prefer Adherence; 2014; 8():415-22. PubMed ID: 24729689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing multiple sclerosis disease-modifying treatment prescribing decisions in the United Kingdom: A qualitative interview study.
    Cameron E; Rog D; McDonnell G; Overell J; Pearson O; French DP
    Mult Scler Relat Disord; 2019 Jan; 27():378-382. PubMed ID: 30500689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing communication changes in persons with multiple sclerosis: Findings from qualitative focus groups.
    El-Wahsh S; Balandin S; Bogaardt H; Kumfor F; Ballard KJ
    Int J Lang Commun Disord; 2022 May; 57(3):680-694. PubMed ID: 35338749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Student and educator experiences of maternal-child simulation-based learning: a systematic review of qualitative evidence protocol.
    MacKinnon K; Marcellus L; Rivers J; Gordon C; Ryan M; Butcher D
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):14-26. PubMed ID: 26447004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How the COVID-19 Pandemic has changed multiple sclerosis clinical practice: Results of a nationwide provider survey.
    Morrison EH; Michtich K; Hersh CM
    Mult Scler Relat Disord; 2021 Jun; 51():102913. PubMed ID: 33839482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Information provision for people with multiple sclerosis.
    Köpke S; Solari A; Khan F; Heesen C; Giordano A
    Cochrane Database Syst Rev; 2014 Apr; (4):CD008757. PubMed ID: 24752330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "A qualitative study of multiple sclerosis specialists' experiences and perspectives in managing family planning in people with multiple sclerosis".
    Fragkoudi A; Rumbold AR; Burke T; Grzeskowiak LE
    Mult Scler Relat Disord; 2024 Feb; 82():105409. PubMed ID: 38176286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge, skills, and confidence gaps impacting treatment decision making in relapsed/refractory chronic lymphocytic leukemia and mantle cell lymphoma: a quantitative survey study in France, Germany, and the United States.
    Peloquin S; Cymbalista F; Dreyling M; Shah NN; Murray S; Del Fiacco R; Muehlenbein CE; Lazure P
    BMC Cancer; 2024 Aug; 24(1):1003. PubMed ID: 39138575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group.
    ; Rieckmann P; Centonze D; Elovaara I; Giovannoni G; Havrdová E; Kesselring J; Kobelt G; Langdon D; Morrow SA; Oreja-Guevara C; Schippling S; Thalheim C; Thompson H; Vermersch P; Aston K; Bauer B; Demory C; Giambastiani MP; Hlavacova J; Nouvet-Gire J; Pepper G; Pontaga M; Rogan E; Rogalski C; van Galen P; Ben-Amor AF
    Mult Scler Relat Disord; 2018 Jan; 19():153-160. PubMed ID: 29241142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.